Tag: Hormones: Misc.
Judge Says Transgender Inmates Must Have Access to Hormone Therapy
Asthma Attacks Increase for Some Women Taking Progestogen-Only Pill
Increased risk for attacks seen in women younger than 35 years, those with eosinophilia, those with lower corticosteroid use
Gender-Affirming Hormone Therapy in Primary Care Tied to Reduced Depressive Symptoms
Findings seen for transgender, nonbinary, and gender-diverse adults
VA Ends Hormone Therapy for Newly Diagnosed Transgender Veterans
Venous Thromboembolism Risk Higher for Certain Hormonal Contraceptives
Standardized VTE rates highest for combined pills, especially those containing third-generation progestins
Gender-Affirming Medication Use Rare in U.S. Transgender Adolescents From 2018 to 2022
Findings seen among privately insured adolescents who identify as transgender and gender-diverse
Recommendations Updated on Diagnosis, Management of Premature/Primary Ovarian Insufficiency
Significant changes from previous guideline include recommendation that only FSH >25 IU required for POI diagnosis
Long-Term Sex Hormone Treatment in Transgender Care Tied to Changes in Body Composition
Longitudinal changes seen in regional fat and muscle composition and cardiometabolic biomarkers
Hormone-Modulating Therapy May Reduce Dementia Risk in Breast Cancer
Greatest reduction seen for women aged 65 to 74 years who self-identify as Black
Racial, Ethnic Differences Seen in Breast Cancer Treatment Declination
American Indian, Alaska Native, other; Asian or Pacific Islander; Black patients more likely to decline surgery
